You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium
|
---|---|
Published in |
Investigational New Drugs, March 2010
|
DOI | 10.1007/s10637-010-9420-8 |
Pubmed ID | |
Authors |
Deborah A. Bradley, Stephanie Daignault, Charles J. Ryan, Robert S. DiPaola, David C. Smith, Eric Small, Mitchell E. Gross, Mark N. Stein, Alice Chen, Maha Hussain |
Mendeley readers
The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 50 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 9 | 18% |
Student > Bachelor | 6 | 12% |
Researcher | 5 | 10% |
Student > Doctoral Student | 4 | 8% |
Professor > Associate Professor | 4 | 8% |
Other | 12 | 24% |
Unknown | 10 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 26% |
Agricultural and Biological Sciences | 6 | 12% |
Biochemistry, Genetics and Molecular Biology | 5 | 10% |
Computer Science | 2 | 4% |
Immunology and Microbiology | 2 | 4% |
Other | 6 | 12% |
Unknown | 16 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2021.
All research outputs
#8,882,501
of 26,017,215 outputs
Outputs from Investigational New Drugs
#395
of 1,286 outputs
Outputs of similar age
#40,340
of 107,728 outputs
Outputs of similar age from Investigational New Drugs
#5
of 11 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,286 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,728 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.